HealthEquity (NASDAQ: HQY) reported Q2 EPS of $0.33, in-line with the analyst estimate of $0.33. Revenue for the quarter came in at $206.1 million versus the consensus estimate of $203.82 million.

GUIDANCE:

HealthEquity sees FY2022 EPS of $1.23-$1.32, versus the consensus of $1.28. HealthEquity sees FY2022 revenue of $834-844 million, versus the consensus of $831.91 million.

For earnings history and earnings-related data on HealthEquity (HQY) click here.